Heart failure in COVID-19 pandemic: Challenging management issues

Patnaik An,Patnaik S

doi:10.17727/jmsr.2020/8s1-9

Abstract

Over these 12 months of coronavirus disease 2019 (COVID-19) pandemic, the patients of heart failure (HF) showed higher risk of severe disease and increased mortality. Their evaluation and treatment when additionally affected with COVID-19 posed many new challenges, as one condition can potentiate the other and there is considerable overlap of their presenting features. The pandemic also impacted the existing health care systems with changed priorities. Known HF patients becoming worse after acquiring the COVID-19 infection or the new development of acute cardiac complications in persons without any prior heart disease- both are novel therapeutic issues which have no perfect answers for want of adequate data and randomised trials. Newer suggestions are emerging in the management of HF with concomitant COVID-19 from experience from various sources. We have to keep our minds open and learn every day. Keywords: heart failure; coronavirus; COVID-19; management; SARS-CoV-2

Highlights

Coronavirus disease 2019 (COVID-19) pandemic is about to complete one-year of its emergence into our lives
Zhou et al found that 23% of their 191 patients of COVID-19 inpatients had heart failure, which was as Journal of Medical and Scientific Research high as 52% among the non-survivors [1]
(c) Heart failure with preserved EF This type of presentation in patients with COVID19 disease is possible by direct viral infiltration, inflammation, or cardiac fibrosis or by unmasking of pre-existing HFpEF

Summary

Introduction

Coronavirus disease 2019 (COVID-19) pandemic is about to complete one-year of its emergence into our lives. Heart failure in COVID-19 pandemic: Challenging management issues. Wang D et al showed that as many as 7.2% of all COVID-19 patients (22% of those requiring ICU admission) presented with acute cardiac injury [4].

Results

Conclusion